Swift Medical’s US$35 Million Series B Financing

Torys represented Swift Medical on the deal.

Swift Medical announced a US$35 million Series B financing. The investment round was led by Virgo Investment Group LLC (“Virgo”), through one of its managed-investment funds, followed by existing investors DCVC, who led their Series A, and BDC Capital, through their Women in Technology Venture Fund. Other participating investors included leading health technology firms Claritas Capital, Chrysalis Ventures, Pender Ventures and Export Development Canada.

Swift Medical provides an AI-powered, digital wound care platform that allows any patient or clinician to easily capture a high precision image of their wound with their mobile phone, autonomously determines wound dimensions and clinical characteristics, enables virtual wound care consultations and provides real-time, predictive insights to drive enhanced preventive and personalized care.

This latest round of funding will help Swift Medical expand their leading market position and scale their digital wound management platform across the care continuum in North America.

Torys represented Swift Medical with a team that included Cheryl Reicin (Picture), Matthew Atkey and Adam Falconi (corporate/life sciences).

Involved fees earner: Matthew Atkey – Torys LLP; Adam Falconi – Torys LLP; Cheryl Reicin – Torys LLP;

Law Firms: Torys LLP;

Clients: Swift Medical;

Author: Martina Bellini